Clinical Trials Directory

Trials / Unknown

UnknownNCT02539381

The Stroke Vision App: A Screening Tool for Visual Stroke

Stroke Vision: A Screening Tool for the Assessment of Visual Impairments in Stroke Survivors

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
62 (estimated)
Sponsor
NHS Greater Glasgow and Clyde · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Visual impairment can affect up to 70% of stroke survivors, but many do not have their vision adequately assessed in hospital. An unidentified visual defect can cause significant problems for recovery and quality of life. The Stroke Vision app (an application currently scaled for a 10" Android tablet) has been developed to act as a screening tool for visual problems in stroke survivors; to help identify visual problems earlier and thereby improve rehabilitation outcomes. The app includes a suite of tests for assessing the patient's acuity, their visual fields and to aid in the identification of visual neglect / inattention. Furthermore, it includes educational information on visual stroke in order to better educate staff, patients and their carers. This study seeks to validate the novel digital assessments included in the Stroke Vision app against the current methods used for screening (clinical examination by confrontation field testing). Both screening measures will be compared with the gold standard methods for visual assessments, Octopus perimetry for fields and paper-based methods for visuospatial neglect

Conditions

Interventions

TypeNameDescription
PROCEDUREFormal Perimetry (Goldman or Octopus visual Field)
PROCEDUREAlbert's visual inattention test
PROCEDUREStar cancellation visual inattention test
PROCEDUREVisual field assessment to confrontation
PROCEDUREVisual inattention assessment to bilateral stimuli
DEVICEDigital tumbling E visual accuity assessment
DEVICEDigital visual field assessment
DEVICEDigital line crossing assessment
DEVICEDigital shape cancellation assessment

Timeline

Start date
2015-07-01
Primary completion
2016-01-01
Completion
2016-01-01
First posted
2015-09-03
Last updated
2015-09-03

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02539381. Inclusion in this directory is not an endorsement.